156 related articles for article (PubMed ID: 19794890)
1. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
Seo J; Pyo H; Lee S; Lee J; Kim T
Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
[TBL] [Abstract][Full Text] [Related]
2. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
Kim T; Son C; Lee J; Kim K
Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
[TBL] [Abstract][Full Text] [Related]
3. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
Suckow MA
Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
Lee J; Woo HJ
J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
[TBL] [Abstract][Full Text] [Related]
5. [The detection of Pasteurella multocida toxin using a commercially available ELISA].
Weber A; Wachowitz R; Singer H; Heil-Franke G
Berl Munch Tierarztl Wochenschr; 1993 Oct; 106(10):328-30. PubMed ID: 8250823
[TBL] [Abstract][Full Text] [Related]
6. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
Hur J; Byeon H; Lee JH
Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
[TBL] [Abstract][Full Text] [Related]
7. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) using recombinant toxin for detection of antibodies against Pasteurella multocida toxin.
Takada-Iwao A; Uto T; Mukai T; Okada M; Futo S; Shibata I
J Vet Med Sci; 2007 Jun; 69(6):581-6. PubMed ID: 17611352
[TBL] [Abstract][Full Text] [Related]
10. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
Rajeev S; Nair RV; Kania SA; Bemis DA
Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
[TBL] [Abstract][Full Text] [Related]
11. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
van Diemen PM; de Vries Reilingh G; Parmentier HK
Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
[TBL] [Abstract][Full Text] [Related]
12. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
Seo J; Lee S; Pyo H; Lee J; Kim T
Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics and immunogenicity of the N-terminal and C-terminal recombinants of Pasteurella multocida toxin].
Tang X; Wu B; Zhao Z; Deng Y; He H; He Q; Chen H
Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):213-9. PubMed ID: 18438004
[TBL] [Abstract][Full Text] [Related]
15. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
To H; Someno S; Nagai S
Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
[TBL] [Abstract][Full Text] [Related]
17. Use of ELISA to detect toxigenic Pasteurella multocida in atrophic rhinitis in swine.
Bowersock TL; Hooper T; Pottenger R
J Vet Diagn Invest; 1992 Oct; 4(4):419-22. PubMed ID: 1457544
[TBL] [Abstract][Full Text] [Related]
18. Serological potency testing of vaccines against progressive atrophic rhinitis.
Oppling V; Kusch M; Rübmann P; Cussler K
Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
[No Abstract] [Full Text] [Related]
19. Toxigenic type A Pasteurella multocida as a causative agent of nasal turbinate atrophy in swine.
Sakano T; Taneda A; Okada M; Ono M; Hayashi Y; Sato S
J Vet Med Sci; 1992 Jun; 54(3):403-7. PubMed ID: 1386531
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.
Lee J; Kang HE; Woo HJ
Clin Vaccine Immunol; 2012 Sep; 19(9):1526-31. PubMed ID: 22837096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
